13 insiders reported 53 Form 4 transactions for Celularity Inc (CELU) over the past 18 months (most recent 2026-04-15). Recent activity: Haines John R (Senior Exec Vice President) Buy 1,641 shares, Hariri Robert J (Chief Executive Officer) Sell 1,182 shares, Brigido Stephen (Pres., Functional Regeneration) Buy 821 shares, Hariri Robert J (Chief Executive Officer) Buy 3,281 shares, Haines John R (Senior Exec Vice President) Sell 583 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | Haines John R | Senior Exec Vice President | Buy | 1,641 | $0 |
| 2026-04-15 | Hariri Robert J | Chief Executive Officer | Sell | 1,182 | $1,513 |
| 2026-04-15 | Brigido Stephen | Pres., Functional Regeneration | Buy | 821 | $0 |
| 2026-04-15 | Hariri Robert J | Chief Executive Officer | Buy | 3,281 | $0 |
| 2026-04-15 | Haines John R | Senior Exec Vice President | Sell | 583 | $746 |
| 2026-04-15 | Brigido Stephen | Pres., Functional Regeneration | Sell | 268 | $343 |
| 2026-01-15 | Diamandis Peter | Director | Buy | 20,385 | $0 |
| 2026-01-15 | LeVien Vincent | Director | Buy | 28,847 | $0 |
| 2026-01-15 | Ling Geoffrey M.D. | Director | Buy | 19,231 | $0 |
| 2026-01-15 | Parks Diane L. | Director | Buy | 30,000 | $0 |
| 2026-01-14 | Ling Geoffrey M.D. | Director | Buy | 19,231 | $0 |
| 2026-01-14 | LeVien Vincent | Director | Buy | 28,847 | $0 |
| 2026-01-14 | Parks Diane L. | Director | Buy | 30,000 | $0 |
| 2026-01-14 | Diamandis Peter | Director | Buy | 20,385 | $0 |
| 2025-12-30 | LeVien Vincent | Director | Buy | 125,000 | $0 |
| 2025-12-30 | Ling Geoffrey M.D. | Director | Buy | 125,000 | $0 |
| 2025-12-30 | Parks Diane L. | Director | Buy | 125,000 | $0 |
| 2025-12-30 | Diamandis Peter | Director | Buy | 125,000 | $0 |
| 2025-12-22 | Ling Geoffrey M.D. | Director | Buy | 67,416 | $0 |
| 2025-12-22 | Diamandis Peter | Director | Buy | 67,416 | $0 |
| 2025-12-22 | Parks Diane L. | Director | Buy | 67,416 | $0 |
| 2025-11-21 | Parks Diane L. | Director | Buy | 61,539 | $0 |
| 2025-11-21 | LeVien Vincent | Director | Buy | 3,699 | $0 |
| 2025-11-21 | Diamandis Peter | Director | Buy | 47,042 | $0 |
| 2025-11-21 | Ling Geoffrey M.D. | Director | Buy | 44,379 | $0 |
Source: SEC Form 4 filings · as of 2026-04-15
